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Abstract 
Bilateral vocal fold paralysis presents as their complete or partial immobilisation. The median or paramedian position of vocal folds 
contributes to the narrowing of the airway at the level of the glottis and manifests as inspiratory dyspnoea. For many years iatrogenic 
injury of recurrent laryngeal nerves during thyroidectomy has been viewed as the most common underlying reason. It is very often a life-
threatening condition requiring not only corticosteroid administration and intubation, which only constitute a short-term symptomatic 
therapy, but also surgical intervention, including tracheostomy. The most common surgical methods implemented in bilateral vocal fold 
paralysis include posterior cordectomy, arytenoidectomy, and, more and more commonly, re-innervation. Other techniques used in 
restoring airway patency include laterofixation, botulinum toxin injection, and laryngeal stimulation, which is still under research. Stem 
cell and gene therapy are also being researched. Notably, the main purpose of surgical treatment is the provision of airway patency with 
the preservation of the phonatory and protective functions of the larynx. (Endokrynol Pol 2020; 71 (4): 350–358)
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Introduction 
Vocal fold immobilisation means a complete or substan-
tial limitation of vocal fold mobility. It may be due to 
bilateral laryngeal nerve paralysis, cricoarytenoid joint 
stiffness, posterior glottic stenosis, and laryngeal adhe-
sions [1, 2]. The diagnosis of one of the above aetiologies 
does not rule out the remaining ones [3]. 
Ten per cent of vocal fold paralysis cases are due 
to central paralysis associated with the damage to 
the structures of the central nervous system [4], such 
as ischaemic stroke, Arnold-Chiari malformation, 
myasthaenia gravis, bulbar poliomyelitis, Parkinson’s 
disease, or multifocal white matter disease [5]. Periph-
eral laryngeal paralysis is considerably more common, 
accounting for 90% of cases. It results from damage to 
the vagus nerve, or the superior laryngeal or recur-
rent laryngeal nerve (RLN) [4], due to an iatrogenic 
injury (26–59%), intubation (1–31%), injury (1–28%), 
and extralaryngeal location of cancer (5–17%) [6]. Ac-
cording to some authors, thyroidectomy is becoming 
a less common reason for vocal fold paralysis due to 
the improvement of surgical techniques, the use of 
neuromonitoring, fine-needle aspiration biopsy, and 
widening indications for conservative treatment in the 
case of benign thyroid pathologies [5]. However, the 
majority of research show that thyroidectomy is still 
the most common cause of iatrogenic damage to the 
RLN [5–7]. Carotid endarterectomy, and surgeries of the 
oesophagus, cervical spine, heart, and lungs may also 
contribute to the damage of the vagus nerve. 
Feehery et al. reported that intubation-associated 
RLN paralysis occurs as a result of neuropraxia when 
the cuff of the intubation tube is located directly below 
the vocal folds compressing RLN fibres where they pen-
etrate through the lamina of the thyroid cartilage [5]. 
Chen et al. also reported that radiotherapy of the 
area of the head and neck may cause cranial nerve 
paralysis because of tissue fibrosis [7]. 
According to English language sources, the idio-
pathic aetiology encompasses from 10 to 27% of all vocal 
fold paralysis aetiologies, while the respective values 
estimated in Japanese professional papers range from 
25 to 41% [8].
The diagnosis of bilateral laryngeal nerve paralysis 
may be made on the basis of physical examination, 
endoscopy, and/or electromyography of the larynx. In 
some cases it is necessary to perform a direct laryngos-
copy to confirm the mobility in the cricoarytenoid joint 
by palpation [9]. 
Patient with bilateral vocal fold paralysis has a nar-
row rima glottidis due to the inability to abduct the 
vocal folds, impaired airway function, inspiratory 
dyspnoea, and vocal disruption. The degree of vocal 
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and severe dyspnoea tracheostomy remains the gold 
standard in patients with immobilised vocal folds [21]. 
Arytenoidectomy 
Depending on its function, the rima glottidis may be 
divided into the phonatory segment (anterior 2/3) 
and respiratory segment (posterior 1/3). The aryte-
noid cartilage is the key element of the posterior part 
of the larynx. Arytenoidectomy (arytenoid cartilage 
removal) is an irreversible surgical method to widen 
the rima glottidis in the transverse axis. The technique 
is widely applied independently or in combination 
with partial resection of the vocal folds [15]. The first 
arytenoidectomy was conducted in 1916 by Baker, who 
simultaneously performed partial cordectomy through 
laryngofissure approach [22]. Iwanoff removed the 
arytenoid cartilage by incising the mucous membrane 
in the medial line of the larynx [23], while Kelly made 
a window in the inferoposterior part of the thyroid 
cartilage [24]. Another approach was described by 
Woodman, who incised the skin parallelly to the ante-
rior edge of the sternocleidomastoid muscle at the level 
of the superior border of the thyroid cartilage accessing 
the cricothyroid joint posteriorly. This approach facili-
tated the preservation of the thyroid cartilage plate as 
a whole, and the remaining vocal process was sutured 
laterally to the inferior horn of the thyroid cartilage 
[25]. A more effective lateralisation and smaller vertical 
shift was obtained by Newman et al., who modified 
the above technique. The vocal process was attached 
via small openings in the thyroid cartilage at the 
level of the cricoarytenoid joint [26]. Helmus described 
arytenoidectomy via thyreofissure approach (only the 
thyroid cartilage was split) under microscopic control 
with the use of microinstruments that allowed for 
the precise dissection of the arytenoid cartilage [27]. 
Arytenoidectomy accessed via medial thyrotomy was 
performed by Perlman and Kilian, who removed the 
cartilage via a small incision of the mucous membrane 
at its medial part. They used electrocoagulation, which 
facilitated the achievement of haemostasis and caused 
the development of scar tissue resulting in the lateral 
positioning of vocal folds [28]. 
In 1948 Thornell described intralaryngeal aryte-
noidectomy with an endoscopic approach [29]. After 
temporary tracheotomy and injecting the vocal fold 
and the aryepiglottic fold with an anaesthetic solu-
tion, an incision was performed above the arytenoid 
cartilage as far as the aryepiglottic fold. The cartilage 
was dissected and removed via the obtained access. Ad-
ditional tissue lateralisation was obtained with the use 
of electrocoagulation and the formation of scar tissue. 
An acrylic stent was placed between vocal folds for 
disruption may vary. Additionally, in the case of simul-
taneous superior laryngeal nerve paralysis, marked 
symptoms of protective dysfunction of the larynx occur, 
including choking when consuming food or drinks, 
dysphagia, and inability to cough with expectoration 
[10]. The varying degree of dyspnoea and associated 
medical problems depends on body weight, concomi-
tant diseases, and basic physical activity [11]. 
Vocal folds may be located in the median or parame-
dian position. However, the location changes over time. 
It may take several years to reach the final position of 
the vocal folds [12] depending on the re-innervation, 
synkinesis, atrophy, and the fibrosis of the denervated 
laryngeal muscle. Woodson claimed that the parame-
dian position of vocal folds is due to the intensified 
re-innervation of the thyroarytenoid muscle and im-
mobility caused by the lack of abduction of the posterior 
cricoarytenoid muscles [13].
From 4 to 14% of patients tolerate this condition 
and require no surgery, while in some cases delayed 
decompensation may occur and surgical intervention 
may be necessary [6, 11]. However, the majority of 
patients with bilateral vocal fold paralysis require treat-
ment that widens the rima glottidis. Since the beginning 
of the 20th century numerous operative techniques 
through external and then endoscopic access have 
been described, indicating the lack of one effective and 
universal method. Otolaryngologists who select a treat-
ment modality need to find a compromise between 
the improvement of ventilation when widening the 
rima glottidis, the maintenance of vocal function, and 
prevention of disrupting the protective function of the 
larynx [14]. Constant modifications are applied to opera-
tive techniques, not only in the case of arytenoidectomy 
or cordectomy, but also electrical laryngeal stimulation 
or re-innervation [15, 16]. Moreover, botulinum toxin 
injections are used in cases of synkinesis in bilateral vo-
cal fold paralysis. Furthermore, gene therapy and stem 
cell therapy are in the experimental phase of research 
[17]. Different treatment methods and their modifica-
tions are described below.  
Tracheostomy 
Tracheostomy is one of the most common procedures 
used in cases of bilateral vocal fold paralysis. It pro-
vides a direct bypass of airway obstruction. Despite 
being a very effective method, it is not preferred by 
the majority of patients [17]; this is due to the presence 
of an open wound [16], necessity of long-term care, 
and reduced quality of life [18, 19]. Naunheim et al. 
reported that endoscopic techniques are less expensive 
than tracheostomy in the treatment of bilateral vocal 
fold paralysis [20]. Nevertheless, in cases of sudden 
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3–4 weeks. Kleinsasser presented a modification of this 
technique in 1968 [30]. He made a longitudinal incision 
in the central part of the superior surface of the vocal 
fold, removed the arytenoid cartilage and two thirds of 
the vocal muscle in this way and obtained submucosal 
hemicordectomy with arytenoidectomy. The incision 
into the mucous membrane was sealed with intrala-
ryngeal sutures.
The use of lasers in surgery led to the exponential 
development of laryngeal microsurgery [17]. Its numer-
ous advantages include a precise line of incision, the 
potential of maintaining haemostasis, and the reduction 
of postoperative oedema [17, 31]. Laryngoscopes offer 
better visibility of the operative field because it is not 
covered with instruments during preparation. In 1983 
Ossoff et al. described endoscopic total arytenoidec-
tomy with the use of a CO2 laser [31]. In their method 
most of the cartilage was removed, then the incision was 
prolonged laterally in order to initiate fibrosis, which 
facilitated vocal fold lateralisation. A slight modifica-
tion was presented by Sato, who preserved the flap of 
the mucous membrane coating the arytenoid cartilage. 
Subsequently, he used fibrin glue to seal the flap over 
the lesion [32]. Subtotal arytenoidectomy was described 
by Remarcle et al. in 1996. It involved the preservation 
only of the posterior part of the cartilage (the so-called 
“shell”) to avert aspiration [33]. A more extensive tech-
nique was presented by Maurizi et al., who performed 
laser subtotal arytenoidectomy and the resection of 
a substantial portion of the posterior part of the vocal 
fold and the vestibular fold [34]. Such an extensive 
procedure has not been widely implemented in spite 
of its 100% success rate in 39 cases reported by the 
authors. Crumley proposed a less radical procedure 
of laser medial arytenoidectomy in order to maintain 
better vocal quality [35]. The cartilage is removed only 
in the central part with the preservation of its lateral 
and posterior part, the vocal process, and cricoaryte-
noid joint. Laser medial arytenoidectomy allows for 
widening of the posterior part of the rima glottidis by 
approx. 1–2 mm. If necessary, the procedure may be 
conducted contralaterally after three months. Googe 
et al. presented endoscopic arytenoidectomy with the 
use of plasma coblation [36]. The method was used in 
one patient with a tracheostomy tube. The patient was 
successfully decannulated eight months later. However, 
no research was conducted on a larger group of patients 
with the use of coblation in the treatment of bilateral 
vocal fold paralysis [17]. 
Cordectomy 
Cordectomy (posterior and transverse) is an irrevers-
ible method of widening the rima glottidis involving 
the excision of part of the vocal fold, vocal ligament, or 
the thyroarytenoid muscle [15]. The first cordectomy 
was described by Hoope in 1896, who performed 
simultaneous tracheotomy in patients. However, the 
operation did not lead to the anticipated effect [15, 37]. 
Several years later, in 1908, Citelli described external 
cordectomy performed via thyreofissure approach [38]. 
Hoover presented Jackson’s technique called “ventricu-
locordectomy”, in which the vocal muscle (forming the 
inferior part of the laryngeal ventricle — referred to 
as “ventriculo-” by the author) was removed through 
the laryngofissure approach, vocal ligament (“cordec-
tomy”), and the vocal process [39]. Surjan modified 
cordectomy performed via thyreofissure approach. He 
created mucous membrane folds in the larynx — one at 
the level of the vestibular fold and another contralater-
ally — in the subglottis. Such an innovation aimed at 
reducing the risk of stenosis [40]. Šercer reported a total 
submucosal bilateral resection of vestibular folds and 
vocal folds along with the anterior part of the arytenoid 
cartilage [41]. The author claimed that only the posterior 
part of the arytenoid cartilages was preserved above 
the cricoid cartilage in the “neolarynx”. He observed 
raspy voice in patients, which was produced by the 
aryepiglottic folds. 
After endoscopic laser surgery was implemented in 
the treatment of bilateral vocal fold paralysis, Dennis 
and Kashima presented their technique in 1989 [42]. 
They used a CO2 laser to excise a C-shaped portion 
of soft tissue in the posterior part of the vocal fold 
with the transection of the elastic cone. They obtained 
decannulation in 60% of patients [42–44], but bilateral or 
repeated cordectomy was necessary in 30% of them [16, 
42]. The technique presented by Dennis and Kashima 
was modified by Pia and Pisani [43]. The resected vocal 
fold was laterally and posteriorly widened along with 
a part of the vestibular fold with a CO2 laser. The mu-
cous membrane lesion was covered with fibrin prepara-
tion. Submucosal anterior cordectomy was performed 
by Eckel. The arytenoid cartilage was intact, and a fold 
of the mucous membrane was sealed with fibrin glue 
to the intralaryngeal lesion [45]. The obtained results 
were consistent with those of conventional laser aryte-
noidectomy [44]. Benninger et al. also presented laser 
posterior cordectomy with submucosal resection of the 
vocal process and formation of a mucous membrane 
flap, which was subsequently sutured laterally to the 
created pocket [46].
Laterofixation
Laterofixation of the vocal fold and/or the arytenoid 
cartilage is a reversible method in the treatment of 
bilateral vocal fold paralysis in adults and children 
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[17]. The technique may be applied independently 
or in combination with other methods of laryngeal 
microsurgery unilaterally or bilaterally [18]. The rima 
glottidis is widened without the destruction of tissues 
responsible for phonation [17]. According to a review 
by Sapundzhiev et al., the fixation of the cricoarytenoid 
joint accessed by laryngofissure was first described by 
Rethi in 1922 [15]. He used an intralaryngeal stent for 
2–3 months postoperatively to maintain the mobilisa-
tion of the arytenoid cartilage laterally. A similar tech-
nique was used by Montgomery, who applied a special 
stainless-steel pin [15]. 
Endoscopic lateralisation with sutures was per-
formed by Kirchner in 1979 [47] and Ejnell in 1982 
[48]. Kirchner performed endoscopic resection of the 
thyroarytenoid muscle with electrocoagulation. Sub-
sequently, he temporarily fixated the vocal fold with 
a suture introduced into the lumen of the larynx [47]. 
Ejnell et al. performed vocal fold lateralisation as an in-
dependent procedure. They visualised the larynx via 
direct laryngoscopy and identified the cricoarytenoid 
joint. Then, with the use of two externally inserted 
needles they tied a knot and lateralised the vocal fold 
[48]. Remsel modified Kirchner’s technique by replacing 
electrocoagulation with a CO2 laser [49]. 
Endo-extralaryngeal access in laterofixation with the 
use of a specially developed needle holder was intro-
duced by Lichtenberger [50, 51], in which sutures are 
placed from the lumen of the larynx, through the lamina 
of the thyroid cartilage, and out onto the skin. He also 
classified laterofixation into reversible endo-extralaryn-
geal, laryngo-microsurgical endo-extralaryngeal lateral-
isation and laryngo-microsurgical endo-extralaryngeal 
lateralisation with arytenoidectomy [51, 52]. Initially, 
the resection was performed with surgical instruments, 
which were subsequently replaced with a CO2 laser. The 
modification of the above techniques was proposed by 
Woodson and Weiss [53, 54]. Lateralisation with sutures 
was performed at the level of the arytenoid cartilage. 
They called it “arytenoid abduction”, and it caused 
postero-caudal traction stimulating the contraction of 
the posterior cricoarytenoid muscle.
Laryngeal stimulation
Research on the functional electrical stimulation of 
paralysed laryngeal muscles has been conducted for 
a few decades [55]. The concept of functional electrical 
stimulation of paralysed muscles of the head, neck, and 
chest was first introduced by Zealear and Dedo [55]. In 
1996 Zealear published a paper in which he confirmed 
that laryngeal stimulation with the use of an external 
device was an effective method for the treatment of 
vocal fold paralysis [56]. Several years later his team 
implanted a stimulator with electrodes in seven pa-
tients [57]. Li et al. reported that unilateral stimulation 
was an effective treatment, which surpassed posterior 
cordectomy as regards postoperative ventilation and 
vocal outcomes [58]. Research on unilateral electrical 
laryngeal stimulation was also described by Mueller 
et al. [59, 60]. They implanted minimally invasive elec-
trodes activated with an external stimulator attached 
to the chest wall in nine patients with bilateral vocal 
fold paralysis. They obtained a considerable ventilation 
improvement without vocal deterioration in the study 
group. The presented results are promising. However, 
further research is necessary to assess the durability of 
electrodes and their capacity to migrate.      
Botulinum toxin injections
Botox is a neurotoxin produced by Clostridium botuli-
num. There are seven serologically distinct toxins (A–G), 
with types A and B being the most commonly used in 
medicine. The neurotoxin inhibits the release of acetyl-
choline from axon ending leading to flaccid paralysis 
[17]. In the treatment of bilateral vocal fold paralysis 
botulinum toxin is used to block laryngeal synkinesis. It 
is a movement disorder resulting from the inappropri-
ate re-innervation following RLN damage. Synkinesis 
occurs when axons of RLN adductor penetrate the 
abductor muscle (posterior cricoarytenoid muscle) 
and/or axons of the abductor integrate into the adductor 
muscles (thyroarytenoid muscle, lateral cricoarytenoid 
muscle, and interarytenoid muscles) [61, 62]. Synkinesis 
may also occur in the case of double innervation of the 
same motor end-plate by afferent and efferent motor 
neurons [63]. The diagnosis of abnormal re-innervation 
may be made on the basis of stroboscopic examination 
or electromyography of the larynx [64]. Marie et al. were 
the first to report a case of Botox injected bilaterally 
to adductor muscles as a treatment for bilateral vocal 
fold paralysis. Ventilation improvement was obtained 
[65]. Botulinum toxin may be applied unilaterally or 
bilaterally, via external access monitored with laryn-
geal electromyography and flexible nasofiberoscope or 
intralaryngeally via direct laryngoscopy under general 
anaesthesia. According to Daniel and Cordona, injec-
tion of botulinum toxin type A into the cricothyroid 
muscles is a quick, effective, and noninvasive modality 
in bilateral vocal fold paralysis and gives the possibility 
of avoiding tracheotomy in the patient [66]. Smith et 
al. injected Botox into the thyroarytenoid muscles in 10 
children (additional injections were administered into 
the cricothyroid muscles in two patients) with bilateral 
vocal fold paralysis under general anaesthesia [67]. 
Ventilation markedly improved in four patients. Ac-
cording to Sahim et al., bilateral injection of botulinum 
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toxin provides temporary relief in dyspnoea in patients 
in whom the prognosis concerning vocal fold mobility 
restoration remains unclear [68].    
Re-innervation 
The methods of surgical treatment of bilateral vocal 
fold paralysis described above do not restore all the 
functions of the larynx, such as appropriate separation 
of vocal folds during breathing, their closure during 
phonation, and the protection of the lower respira-
tory tract when swallowing. Therefore, laryngeal 
re-innervation should be the most effective modality. 
In 1973 Miehlike described his technique, which had 
been initially developed in an animal model and then 
performed in humans. It was called ramus posterior 
shunt [69]. The distal part of the posterior branch of 
the RLN, which innervates the abductor muscle, was 
transected and fixed to the main bundle of the RLN 
bifurcating from the vagal trunk, while the distal part 
of the anterior branch of the RLN, which supplies ad-
ductor muscles, was dissected [70]. The procedure did 
not have followers [15].  
Re-innervation involves the use of the phrenic nerve, 
which was reported by Marina et al. [70]. A branch of 
the phrenic nerve is the only part that can be used for 
anastomosis to minimise the reduction of the mobil-
ity of the diaphragm and respiratory capacity. Li et al. 
obtained an improvement in 41 out of 44 patients who 
had undergone laryngeal re-innervation with the use of 
the left phrenic nerve. A marked improvement in dia-
phragmatic mobility (40–82%) and respiratory function 
was observed in the study group over a year following 
the procedure [71]. A technique described by Tucker 
involved the implantation of a part of the omohyoid 
muscle or the sternohyoid muscle innervated by the 
hypoglossal nerve to the posterior cricothyroid muscle 
[15, 72]. Long-term outcomes are very promising – im-
provement in the patency of the airway was noted in 
80% of patients [72, 73]. Tanaka et al. transplanted a pe-
dunculated neuro-muscular flap using the ansa cervi-
calis nerve to the paraglottic space during thyroid cancer 
resection [74]. They did not observe vocal fold atrophy 
over a two-year follow up, and the phonatory function 
of the larynx was rated as good. However, they did not 
confirm the re-innervation of the thyroarytenoid muscle 
or the lateral cricoarytenoid muscles with EMG examina-
tion. The direct anastomosis of the ansa cervicalis nerve 
with the proximal part of the RLN in an animal model 
led to the re-innervation of adductor muscles of the 
larynx [75, 76]. The results were confirmed with EMG 
and immunohistochemical examinations.  
Marie et al. presented a slightly more complicated 
technique of selective re-innervation in bilateral vocal 
fold paralysis [77]. Posterior cricoarytenoid muscles 
were bilaterally re-innervated by the right superior 
branch of the phrenic nerve, while adductor muscles 
of the larynx were bilaterally re-innervated by the thy-
rohyoid branches of the hypoglossal nerve. Kwak et al. 
modified this technique by using a Y-shaped free graft 
to anastomose the phrenic nerve with bilateral extrala-
ryngeal RLN stumps [78]. None of the above methods 
prevents synkinesis. Li et al. performed a double free 
graft of a nerve in selective re-innervation [79]. One 
Y-shaped free graft was used to anastomose the 
superior branch of the phrenic nerve with bilateral 
RLNs. The second, longer cable graft was used to attach 
the thyrohyoid branch of the hypoglossal nerve with 
the branch of RLN adductors so that axon regeneration 
from various donors to adductor and abductor muscles 
of the larynx occurred over the same length. The au-
thors also stated that synkinesis may be prevented by 
the intralaryngeal transection of the interarytenoid 
branch of the RLN adductor and ligation of the distal 
nerve stump, while the proximal stump should be im-
planted to the posterior cricoarytenoid muscles. The 
technique was implemented in seven patients with 
the resultant improvement of aerodynamic parameters 
and lung function test. Moreover, EMG performed 
12 months after the procedure showed full interference 
potentials in the thyroarytenoid muscles bilaterally 
during phonation and in the posterior cricoarytenoid 
muscles on inspiration.  
Despite a variety of re-innervation techniques, 
a study concerning nerve reconstruction in an animal 
model demonstrated that free grafts of nerves or neuro-
muscular plates are not as histologically and physiologi-
cally effective as direct end-to-end anastomosis [80].   
Gene therapy
The aim of gene therapy in the treatment of bilateral 
vocal fold paralysis is to deliver genes to damaged 
neurons and/or denervated muscles in order to facilitate 
the regrowth of damaged nerve cells and restoration 
of laryngeal muscles [17]. The genes code neurotrophic 
factors that promote neuron survival or growth fac-
tors that stimulate the proliferation and differentia-
tion of stem cells [81]. Genes are delivered by vectors 
injected into the RLN or laryngeal muscles [17]. They 
are absorbed by muscle cells or nerve cell bodies via 
retrograde axonal transport [82, 83]. After transduction 
they produce peptides that promote RLN regeneration, 
synapse formation, and muscle growth. Shiotani et al. 
published the results of their research conducted on 
a rat model. They injected a gene — insulin-like growth 
factor 1 — to the thyroarytenoid muscle of denervated 
larynges. They observed a substantial increase in the 
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diameter of muscle fibres and the percentage of mo-
tor plates adjacent to axons in the muscle in the study 
group compared to the control group [84–86]. Saito et al. 
conducted a study in which an adenovirus vector that 
coded the neurotrophic factor arising from a line of glial 
cells was injected into the nucleus ambiguus after tran-
secting the vagus nerve [87]. They noted a reduction in 
the loss of motoneurons in the nucleus ambiguus after 
four weeks following the injection and the resumption 
of neural function via the increased suppression of the 
activity of nitric oxide synthase and amelioration of the 
immunoreactivity of choline acetyltransferase. Araki et 
al. published the results of an injection of an adenovirus 
vector with a neurotrophic factor arising from a line of 
glial cells into the crushed RLN in a rat model [88]. They 
demonstrated that the study group animals developed 
a markedly larger axon diameter, improved remyelin-
ation, and an increased velocity of nerve conduction 
in comparison with the control group. However, the 
studies are in the experimental phase in animals. The 
results revealed that the method does not prevent the 
occurrence of synkinesis [17, 82].
Stem cell therapy
Stem cell transplantation is a method facilitating tis-
sue regeneration. Muscle stem cells constitute a good 
basis for the attenuation of the atrophy of muscle bulk 
and contribute to its regrowth. In 2007 Halum et al. 
described the use of autologous stem cells arising from 
muscles in the treatment of bilateral vocal fold paralysis 
in a rat model [89]. They observed poor adduction of 
vocal folds after the activation of glottic closure reflex 
in two out of eight study group animals, while no such 
response was noted in the control group. Nishio et al. 
injected adipose-derived regenerative cells into the 
denervated vocal fold in pigs [90]. They reported the 
hypertrophy of the muscle fibre of the thyroarytenoid 
muscle over the month after the injection. Currently, 
research is being conducted on stem cell therapy. 
Similarly to gene therapy, this method does not prevent 
laryngeal synkinesis [17]. 
Discussion
The main purpose of the treatment of bilateral vocal 
fold paralysis is to facilitate effortless breathing in the 
patient. Nevertheless, the provision of good quality of 
life in those patients also includes the restoration of 
the remaining functions of the larynx, such as phona-
tion and swallowing. According to Jackowska et al., 
the most important indices of treatment effectiveness 
in patients with tracheostomy are the rate and time of 
decannulation [91]. Therefore, it seems to be of utmost 
importance to avert tracheostomy by the fastest possible 
revision of the neck in case of iatrogenic bilateral vocal 
fold paralysis, and to perform end-to-end anastomosis 
if nerve discontinuation is confirmed. According to 
the literature, spontaneous restoration of vocal fold 
mobility is highly uncommon, so numerous surgical 
techniques have been developed to widen the rima 
glottidis in patients whose normal laryngeal function 
is not spontaneously restored. Progress was initially 
obtained with the introduction of endoscopic surgery, 
and then with CO2 laser usage. The advantages of the 
method include its precision, provision of haemosta-
sis, and the reduction of intraoperative oedema [92]. 
However, the techniques are not ideal, as they may 
lead to the development of granulation tissue, adhe-
sions, vocal deterioration, dysphagia, aspiration, and 
the inflammation of cricoid cartilage perichondrium. 
The procedures of static glottic enlargement consist of 
the removal of laryngeal tissue (arytenoidectomy, cor-
dectomy) or shifting anatomic structures (laterofixation 
of the vocal fold or arytenoid abduction). They are the 
most common and provide the instant effect of improv-
ing airway function. Moreover, laterofixation may be 
regarded as an alternative to tracheostomy, because of 
its reversibility and minimal impairment of vocal and 
swallowing functions [17]. Other techniques, such as 
Botox injections, re-innervation, or laryngeal stimula-
tion, are indicated in patients with bilateral vocal fold 
paralysis in whom laryngeal synkinesis is observed. 
The techniques involve the physiological restoration 
of laryngeal function without the necessity to perform 
tissue resection. Gene therapy and stem cell therapy 
are currently in the experimental phase in animal 
models. They aim at the promotion of the regrowth of 
neurons and atrophic muscle cells. However, they do 
not prevent the development of synkinesis.  
Two modalities are preferred at the Department of 
Otorhinolaryngology, Head and Neck Surgery of the 
Medical University of Warsaw. The selection of a modal-
ity depends on the duration of bilateral vocal fold pa-
ralysis. Laryngeal re-innervation including end-to-end 
anastomosis in the case of nerve discontinuation is 
performed for the first six months following iatrogenic 
bilateral injury to the RLN. Laser posterior cordectomy 
combined with partial arytenoidectomy in selected 
cases is performed if over six months have passed since 
the diagnosis of bilateral vocal fold paralysis. 
Conclusions
In conclusion, the treatment of bilateral vocal fold 
paralysis constitutes a considerable challenge for ENT 
physicians. The preservation of functional voice, pre-
vention of aspiration and dysphagia, and simultaneous 
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improvement of airway function is particularly difficult. 
Despite the fact that a variety of operative techniques 
are available, their effectiveness has been compared and 
no distinct consensus has been developed as regards 
the best modality.  
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